Invention Grant
- Patent Title: Unit aerosol doses for anticoagulation
-
Application No.: US15317282Application Date: 2016-01-20
-
Publication No.: US10668015B2Publication Date: 2020-06-02
- Inventor: Rangachari Narasimhan , Gregory Marcus
- Applicant: InCarda Therapeutics, Inc. , The Regents of the University of California
- Applicant Address: US CA Newark US CA Oakland
- Assignee: InCarda Therapeutics, Inc.,The Regents of the University of California
- Current Assignee: InCarda Therapeutics, Inc.,The Regents of the University of California
- Current Assignee Address: US CA Newark US CA Oakland
- Agency: Davis, Brown, Koehn, Shors & Roberts, P.C.
- Agent Sean D. Solberg
- International Application: PCT/US2016/014126 WO 20160120
- International Announcement: WO2016/118625 WO 20160728
- Main IPC: A61P7/02
- IPC: A61P7/02 ; A61K9/00 ; A61K31/4709 ; A61K31/727 ; A61K31/4365 ; A61K31/616 ; A61K31/37 ; A61K31/4465 ; A61K38/12
Abstract:
Disclosed herein are methods for prophylactic treatment of acute coronary syndrome (ACS) comprising administering, by inhalation, an effective amount of a pharmaceutical composition comprising at least one anticoagulant or antiplatelet agent to a subject in need thereof, wherein the anticoagulant or antiplatelet agent first enters the heart via the left atrium.
Public/Granted literature
- US20180008540A1 UNIT AEROSOL DOSES FOR ANTICOAGULATION Public/Granted day:2018-01-11
Information query
